Key facts
- It has raised $3.3M across 1 recorded rounds; the latest was Seed Round ($2.3M) in Jun 2024.
- Notable investors include MedTech Innovator, SBXi, Kakao Ventures, Bass Investment.
- Magnendo has filed 2 Form Ds with the SEC, most recently Oct 2024 ($2.3M sold to 37 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Magnendo
Funding rounds
1 roundsAbout Magnendo
Developer of an AI-powered medical imaging platform designed to assist clinicians in detecting and analyzing gastrointestinal conditions with improved accuracy. The company offers advanced image processing algorithms, real-time diagnostic support, integration with endoscopic devices, secure cloud-based data storage, and automated reporting features, enabling healthcare providers, hospitals, and gastroenterology specialists to enhance diagnostic precision, reduce interpretation time, and improve patient outcomes through streamlined workflows and reliable clinical insights.
- Sector
- Healthcare
- HQ
- Newton, MA, United States
- Founded
- 2024
- Employees
- 2
- Website
- magnendo.com/
- Ownership
- Privately Held (backing)
Magnendo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Magnendo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Magnendo in its N-PORT filings yet. We sweep new filings monthly.